NHS Logo
  • Home
  • Impact
  • About Us
    • Contact Us
    • NIHR Imperial BRC Team
    • Equality, Diversity and Inclusion (EDI) Strategy
    • NIHR Infrastructures
    • Acknowledgement
    • Research Guidance & Useful Links
    • NIHR Imperial BRC Branding Guidance
  • Research
    • Biomedical Engineering
    • Brain Sciences
    • Cardiovascular
    • Digestive Diseases
    • Digital Health
    • Immunology
    • Infection & Antimicrobial Resistance
    • Metabolic & Endocrinology
    • Molecular Phenotyping
    • Multiple Long-term Conditions (MLTC)
    • Pregnancy & Prematurity
    • Respiratory
    • Social, Genetic & Environmental Determinants of Health (SGE)
    • Surgery & Cancer
  • Facilities/Services
    • Clinical Imaging Facility
    • Clinical Phenotyping Centre
    • Flow Cytometry
    • Genomics Facility
    • Imperial College Healthcare Tissue Bank
    • iCARE
    • Imperial Clinical Trials Unit
    • Imperial Health Knowledge Bank (IHKB)
    • Organoid Facility
    • Patient Experience Research Centre (PERC)
    • The Leonard and Dora Colebrook Laboratory
  • Patient/Public
    • Research We Are Supporting
    • How You Can Get Involved
    • Information for Researchers
    • Public Involvement, Engagement and Participation in Research Summary Strategy
  • Industry/Partners
    • NIHR Imperial BRC Primary Care Research Unit (PCRU)
    • Collaborations
    • Contract
    • Commercialisation
  • Training
    • Non-Medical Opportunities
    • Chain Florey Clinician Scientist Programme
    • Clinical Academic Training Office
    • Other Training Schemes
  • News & Events
    • Upcoming Events
    • Newsletter

Therapeutic Stories

Therapeutic New class of menopause drugs reduces number and severity of hot flushes in just three days

Therapeutic New class of menopause drugs reduces number and severity of hot flushes in just three days

Published on 19th March 2018
DiagnosticPreventionTherapeutic Mother’s microbiome as a predictor of premature labour

DiagnosticPreventionTherapeutic Mother’s microbiome as a predictor of premature labour

Published on 23rd February 2018
PartnershipTherapeutic Partnering with Heptares to accelerate translational research in gastrointestinal disease

PartnershipTherapeutic Partnering with Heptares to accelerate translational research in gastrointestinal disease

Published on 22nd January 2018
First in HumanInnovationPartnershipTherapeutic Imperial-developed cancer drug enters phase I clinical trial

First in HumanInnovationPartnershipTherapeutic Imperial-developed cancer drug enters phase I clinical trial

Published on 12th January 2018

DiagnosticInformatics ApproachesInnovationTherapeutic ITMAT Call for Proposals 2018

Published on 10th January 2018
Information for Patients and the Public
  • Research We Are Supporting
  • How You Can Get Involved
  • Public Involvement, Engagement and Participation in Research Summary Strategy
Latest News
  • PPIE Winner of the Public Involvement in Research Competition 2025 Announced
  • Prevention Ambitious Prostate Cancer Screening Study, TRANSFORM, Commences with First Participants
  • PPIE Community Partners Take the Lead in Shaping PPIE in Cancer Research
NIHR Imperial Biomedical Research Centre

The National Institute for Health and Care Research (NIHR) Imperial Biomedical Research Centre (BRC) is part of the NIHR and hosted by Imperial College Healthcare NHS Trust in partnership with Imperial College London


Accessibility
Privacy
Terms & Conditions

The information contained in this website is for general use only. We endeavour to keep the information on the site up to date and correct, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose.

© 2025 - NIHR Imperial Biomedical Research Centre